AIDS researchers hail major breakthrough
Lab tests show, for the first time, a vaccine the researchers have developed produces antibodies that block the infection of multiple HIV strains, an elusive scientific goal that has been pursued for more than a decade.
It is expected the vaccine will be employed in clinical trials within the next 18 months.
Lunchtime News
Newsletter
Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.



